Results 141 to 150 of about 2,481,651 (309)
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska +13 more
wiley +1 more source
A photo of Eugene McDermott, likely taken around the time he was a graduate student at Columbia University. He was a founder of GSI, and in the early years developed innovative designs for instruments that improved the business of ...
Texas Instruments Incorporated
core
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura +19 more
wiley +1 more source
[Texas Instruments Press Releases, April-May 1966]
1. Release dated April 1, 1966 is in regard to a brochure (PEP-2) published by Metals & Controls, Inc. on innovations in contact materials and value analysis on contact applications. 2.
Texas Instruments Incorporated
core
Pair‐wise comparison of the CellSearch and FETCH enrichment technologies for circulating tumor cells (CTCs) from metastatic breast, prostate, and small cell lung cancer patients shows an increased capture of CTCs using FETCH enrichment. The clinical implementation of circulating tumor cells (CTCs) as a predictive tool for therapy efficacy in the ...
Michiel Stevens +6 more
wiley +1 more source
[Texas Instruments Press Releases, October-December 1967]
1. Press release dated October 2, 1967 is in regard to an address to the Boston Security Analysts Society by T.I. President and COO Mark Shepherd, Jr. on TI's past and current operations and future plans. Portions of Mr. Shepherd's remarks are reproduced.
Texas Instruments Incorporated
core
Matched spatial transcriptomics and single‐nuclei RNA‐seq were generated for anaplastic and BRAFV600E papillary thyroid cancers revealing generic and tumor‐specific states occurring in cancer cells and in the tumor microenvironment. In this context, cancer dedifferentiation mirrored organoid maturation through ordered thyroid marker gain/loss ...
Adrien Tourneur +11 more
wiley +1 more source
[Texas Instruments Press Releases, March 1970]
1. Press release dated March 2, 1970 is in regard to TI's annual sales and earnings report for 1969. It includes a consolidated financial summary. 2. Press release dated March 2, 1970 announces the appointment of Richard W. Renzetti as President of Texas
Texas Instruments Incorporated
core
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington +10 more
wiley +1 more source

